Sökning: id:"swepub:oai:DiVA.org:liu-47133" > Distribution and Fu...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06516naa a2200577 4500 | |
001 | oai:DiVA.org:liu-47133 | |
003 | SwePub | |
008 | 091011s2008 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:0785375a-ac66-4a41-a675-01eca466fca0 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-471332 URI |
024 | 7 | a https://doi.org/10.1016/j.eururo.2007.10.0242 DOI |
024 | 7 | a https://lup.lub.lu.se/record/11405802 URI |
040 | a (SwePub)liud (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Streng, T.u Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland, Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden4 aut |
245 | 1 0 | a Distribution and Function of the Hydrogen Sulfide-Sensitive TRPA1 Ion Channel in Rat Urinary Bladder |
264 | 1 | b Elsevier BV,c 2008 |
338 | a print2 rdacarrier | |
520 | a Objectives: To investigate the distribution of the transient receptor potential (TRP) A1 ion channel in the rat urinary bladder, and to study the effects of hydrogen sulfide (H2S) and known TRPA1 activators on micturition in conscious rats and on heterologously expressed ion channels. Methods: The expression of TRPA1 in urinary bladder was studied with fluorescence immunohistochemistry and real-time PCR in female Sprague-Dawley rats. Cystometric investigations were performed in conscious animals subjected to intravesical administration of sodium hydrogen sulfide (NaHS, donor of H2S), allyl isothiocyanate (AI), and cinnamaldehyde (CA). Fluorometric calcium imaging was used to study the effect of NaHS on human and mouse TRPA1 expressed in CHO cells. Results: TRPA1 immunoreactivity was found on unmyelinated nerve fibres within the urothelium, suburothelial space, and muscle layer as well as around blood vessels throughout the bladder. All TRPA1 immunoreactive nerves fibres also expressed TRPV1 immunoreactivity and vice versa. TRPA1 was also detected in urothelial cells at both transcriptional and protein levels. AI increased micturition frequency and reduced voiding volume. CA and NaHS produced similar changes in urodynamic parameters after disruption of the urothelial barrier with protamine sulfate. NaHS also induced calcium responses in TRPA1-expressing CHO cells, but not in untransfected cells. Conclusions: The expression of TRPA1 on C-fibre bladder afferents and urothelial cells together with the finding that intravesical TRPA1 activators initiate detrusor overactivity indicate that TRPA1 may have a role in sensory transduction in this organ. The study also highlights H2S as a TRPA1 activator potentially involved in inflammatory bladder disease. © 2007. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng |
653 | a Cystometry | |
653 | a Hydrogen sulfide | |
653 | a Micturition | |
653 | a Rat | |
653 | a Sensory neurons | |
653 | a Transient receptor potential ion channels | |
653 | a TRPA1 | |
653 | a TRPV1 | |
653 | a Urinary bladder | |
653 | a Urothelium | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Högestätt, Edwardu Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine,Högestätt, E.D., Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden4 aut0 (Swepub:lu)kfar-eho |
700 | 1 | a Hedlund, Petteru Lund University,Lunds universitet,Linköpings universitet,Klinisk farmakologi,Hälsouniversitetet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)kfar-phe |
700 | 1 | a Andersson, D.A.u Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom4 aut |
700 | 1 | a Jordt, S.-E.u Department of Pharmacology, Yale University School of Medicine, New Haven, CT, United States4 aut |
700 | 1 | a Bevan, S.u Wolfson Centre for Age-Related Diseases, King's College London, London, United Kingdom4 aut |
700 | 1 | a Andersson, Karl-Eriku Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine,Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC, United States4 aut0 (Swepub:lu)kfar-kea |
700 | 1 | a Hogestatt, E.D.u Högestätt, E.D., Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden4 aut |
700 | 1 | a Zygmunt, Peteru Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine,Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Sweden4 aut0 (Swepub:lu)kfar-pzy |
700 | 1 | a Sturesson, Helenau Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)klin-hax |
710 | 2 | a Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland, Department of Clinical Chemistry and Pharmacology, Lund University Hospital, Lund, Swedenb Avdelningen för klinisk kemi och farmakologi4 org |
773 | 0 | t European Urologyd : Elsevier BVg 53:2, s. 391-400q 53:2<391-400x 0302-2838x 1873-7560 |
856 | 4 | u http://dx.doi.org/10.1016/j.eururo.2007.10.024y FULLTEXT |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-47133 |
856 | 4 8 | u https://doi.org/10.1016/j.eururo.2007.10.024 |
856 | 4 8 | u https://lup.lub.lu.se/record/1140580 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.